Oculogica’s New Patent Opens Potential for a CTE Test for Live Subjects

Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology

Read More →

Oculogica Adds to IP Portfolio with Patent for Assessment of Impairment Due to Cannabis

Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection

Read More →

Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners

Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic

Read More →

Australia’s TGA Grants Approval to First Objective Concussion Diagnostic

Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.

Read More →

Oculogica Adds to IP Portfolio with Patent for Glaucoma

Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.

Read More →

Oculogica’s Drs. Rosina and Uzma Samadani Named in Fast Company’s Annual List of the Most Creative People in Business

Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.

Read More →

These sisters invented a better way to diagnose concussions by tracking eye movement

Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed by sisters Uzma and Rosina Samadani.

Read More →

EyeBOX Featured in Weekly Interview with The Daily Show’s Trevor Noah & Microsoft President Brad Smith

Watch our EyeBOX technology featured in Trevor Noah’s and Microsoft President Brad Smith’s discussion with Green Bay Packers President & CEO Mark Murphy.

Read More →

Midwest Orthopaedics at Rush Acquires New Eye Tracking Technology to Better Assess Concussion

Midwest Orthopaedics at Rush (MOR) is the first in Illinois to offer a new eye-tracking technology to more quickly identify a patient with ocular changes after a potential concussion or traumatic brain injury.

Read More →

TitletownTech leads $8 million round of funding for Oculogica

TitletownTech today announced it has invested in Oculogica, an innovative digital health company, by leading an $8 million round of funding that recently closed.

Read More →

Recent Blog Posts

New posts coming soon

Scroll to Top